Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma.
Cell Biol Int. 2021 Dec;45(12):2499-2509. doi: 10.1002/cbin.11695. Epub 2021 Sep 15.
Cell Biol Int. 2021.
PMID: 34460138
Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
Meshram DD, Pike CVS, Coussons PJ.
Meshram DD, et al. Among authors: pike cvs.
Eur J Pharmacol. 2017 Nov 15;815:332-342. doi: 10.1016/j.ejphar.2017.09.035. Epub 2017 Sep 22.
Eur J Pharmacol. 2017.
PMID: 28943101
Item in Clipboard
Membrane Association of the Short Transglutaminase Type 2 Splice Variant (TG2-S) Modulates Cisplatin Resistance in a Human Hepatocellular Carcinoma (HepG2) Cell Line.
Meshram DD, Fanutti C, Pike CVS, Coussons PJ.
Meshram DD, et al. Among authors: pike cvs.
Curr Issues Mol Biol. 2024 May 2;46(5):4251-4270. doi: 10.3390/cimb46050259.
Curr Issues Mol Biol. 2024.
PMID: 38785527
Free PMC article.
Item in Clipboard
Cite
Cite